Connection

Paolo Calabresi to Parkinsonian Disorders

This is a "connection" page, showing publications Paolo Calabresi has written about Parkinsonian Disorders.
Connection Strength

0.924
  1. Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease. Neurobiol Dis. 2018 10; 118:1-8.
    View in: PubMed
    Score: 0.630
  2. Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias. Neurobiol Dis. 2017 Dec; 108:54-64.
    View in: PubMed
    Score: 0.149
  3. Intermittent theta-burst stimulation rescues dopamine-dependent corticostriatal synaptic plasticity and motor behavior in experimental parkinsonism: Possible role of glial activity. Mov Disord. 2017 Jul; 32(7):1035-1046.
    View in: PubMed
    Score: 0.145
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.